ACS Low Risk Discharge Eligibility Tool

ACS Low Risk Discharge Eligibility Tool Explanation and Clinical Context This tool provides a structured bedside approach to identify patients with acute coronary syndrome who may be suitable for early hospital discharge once initial management is complete. It is intended for use after the acute phase when the treating team is considering discharge and when electrocardiography biomarkers and imaging data are already available. The tool combines simple clinical items with length of stay and the Zwolle score for patients with ST elevation myocardial infarction treated with primary PCI.

For patients with ST elevation myocardial infarction who undergo primary PCI studies summarized in the two thousand twenty five guideline support an early discharge strategy shorter than three days in carefully selected low risk patients. The guideline highlights the Zwolle score as a practical clinical tool to identify patients with low risk of death defined by a score equal or below three who can be considered for discharge between forty eight and seventy two hours after admission when they are clinically stable. Factors that contribute to risk in the Zwolle score include age Killip class post procedural TIMI flow grade presence of three vessel disease anterior infarction and total ischemic time.

Patients who satisfy these conditions and have no complications often have favourable short term outcomes when discharged early. For both ST elevation and non ST segment elevation acute coronary syndrome the same guideline stresses that candidates for early discharge should be clinically stable without recurrent ischemia acute kidney injury left ventricular dysfunction clinical heart failure or significant procedural complications and should have adequate support after discharge. Adequate support includes reliable access to medications early clinical follow up and a safe living environment.

Small retrospective studies suggest that very early or same day discharge after PCI can be safe in selected patients with acute coronary syndrome especially when troponin concentrations are negative or falling and when the above stability criteria are fulfilled. High sensitivity cardiac troponin measurement is central to risk stratification in acute coronary syndrome. The guideline recommends serial high sensitivity cardiac troponin testing and notes that very low concentrations at presentation together with minimal change over one to two hours have very high negative predictive value for myocardial infarction.

In patients with confirmed infarction a falling pattern toward lower levels is expected before discharge and supports clinical stability when considered together with symptoms and electrocardiographic findings. Before discharge all patients with acute coronary syndrome should have assessment of left ventricular ejection fraction because this measurement guides therapy and long term risk assessment. Identification of reduced ejection fraction can trigger initiation of evidence based treatment for heart failure and consideration of device therapy in selected patients.

This tool is designed to complement rather than replace clinical judgement. It should always be applied within the context of local protocols availability of cardiac rehabilitation and shared decision making with the patient and family. When the tool suggests a low risk profile but the clinician has residual concern the safer course is to extend observation or perform further testing.

Conversely when the tool indicates higher risk the team should address modifiable factors optimise treatment and individualise the timing of discharge. Reference Rao SV O Donoghue ML Ruel M et al. two thousand twenty five ACC AHA ACEP NAEMSP SCAI guideline for the management of patients with acute coronary syndromes. Journal of the American College of Cardiology. two thousand twenty five volume eighty five pages two one three five to two two three seven.